Quantitative analysis for BGM Group Ltd. (BGM) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (55.0) (grade B). 27 signals analyzed (23 differentiated alt-data).
BGM stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $0.35 | $0.33 | $0.33 |
| 2026-05-08 | $0.31 | $0.28 | $0.29 |
| 2026-05-20 | $0.33 | $0.28 | $0.29 |
| 2026-06-02 | $0.35 | $0.32 | $0.32 |
| 2026-06-12 | $0.39 | $0.34 | $0.38 |
| 2026-06-25 | $0.35 | $0.32 | $0.32 |
| 2026-07-08 | $0.35 | $0.30 | $0.31 |
| 2026-07-20 | $0.30 | $0.25 | $0.27 |
| 2026-07-30 | $0.29 | $0.26 | $0.27 |
| 2026-08-12 | $0.32 | $0.28 | $0.29 |
| 2026-08-24 | $0.26 | $0.23 | $0.25 |
| 2026-09-03 | $0.28 | $0.26 | $0.28 |
How BGM Group Ltd. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| PDSB | PDS Biotechnology Corporation | $57M | — |
| FLNA | Filana Therapeutics, Inc. | $60M | — |
| TCRX | TScan Therapeutics, Inc. | $61M | — |
| CHRN | Ekso Bionics Holdings, Inc. Common Stock | $56M | — |
View all Health Care stocks by valuation and signals →
BGM Group Ltd. (BGM) scores Buy (55.0), and the composite conceals a 78-point disagreement between its dimensions. It is strongest on ML forecast at 80 and valuation at 78, and weakest on technicals at 2. A stock can carry ML forecast that high while technicals sits at 2; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 80 |
| valuation | 78 |
| technicals | 2 |
StoQuant analyzes 27 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on BGM Group Ltd. (BGM): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/BGM"><img src="https://stoquant.com/badge/BGM.svg" alt="BGM Group Ltd. (BGM) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.